Surgery News

Women and adults who reside in low-income areas are more likely to die 30 days after cardiac surgery compared with men and those living in higher-income ZIP codes, according to a nationwide database analysis.

Oral calcium supplementation with or without vitamin D was associated with lower survival and a greater need for aortic valve replacement among older patients with mild to moderate aortic stenosis, researchers reported.

Duration of LDL-lowering therapy had a cumulatively beneficial effect on CV outcomes, according to a meta-analysis of 21 randomized clinical trials published in Circulation: Cardiovascular Quality and Outcomes.

Alcohol septal ablation for obstructive hypertrophic cardiomyopathy was associated with greater rate of 10-year all-cause death compared with septal myectomy, researchers reported.

The FDA approved the Thoraflex Hybrid Frozen Elephant Trunk device for commercial sale in the U.S. for treatment of adults with complex aortic arch disease, according to an industry press release.

LivaNova announced it received regulatory approvals and has initiated a targeted commercial launch if its patient-tailored monitoring system for use during cardiopulmonary bypass procedures.

WASHINGTON — There have been many changes in intervention since Alain Cribier, MD, FASC, FESC, performed the first-in-human transcatheter aortic valve replacement in a patient with severe aortic stenosis who was not a candidate for surgery.

WASHINGTON — Aggressive intraoperative warming during major noncardiac surgery did not reduce myocardial injury, site infections, transfusion requirement or hospitalization stay vs. routine temperature management, a speaker reported.

WASHINGTON — The 5-year rate of structural valve deterioration was lower in self-expanding valves for transcatheter aortic valve replacement than in surgical valves, researchers reported.

WASHINGTON — In patients with three-vessel CAD, those who underwent fractional flow reserve-guided PCI had similar quality of life at 1 year compared with those who underwent CABG, according to new data from the FAME 3 trial.